Signs, Symptoms, and the Challenge of Getting a Diagnosis

Recognizing genetic peripheral neuropathy can be challenging because its symptoms often develop slowly over many years and can look very similar to other, more common conditions. Because these conditions are rooted in your DNA, the “warning signs” may have been present since childhood, even if they weren’t recognized as medical issues at the time ^[1][2].

Classic Physical Hallmarks

The way genetic neuropathy shows up in the body depends heavily on which subtype you have. Doctors often look for specific “clues” in your physical structure and symptom patterns:

• Charcot-Marie-Tooth (CMT): The most common signs are pes cavus (very high foot arches) and hammertoes (toes that curl downward) ^[2]. Over time, the muscles in the lower legs may thin out, creating a “stork leg” or “inverted champagne bottle” appearance ^[3]. This muscle loss often leads to foot drop, where it is difficult to lift the front of the foot while walking, causing frequent tripping or a high-stepping gait ^[4].
• HNPP: Instead of steady progression, this condition often causes sudden, temporary episodes of numbness or weakness ^[5]. These “pressure palsies” happen when a nerve is lightly compressed—for example, your hand going “dead” for weeks after leaning on your elbow while typing ^[2].
• HSAN: The primary hallmark is a profound loss of pain and temperature sensation ^[6]. This can be dangerous because patients may develop burns or sores on their feet without feeling them, leading to severe infections ^[7].
• hATTR (FAP): This often starts with “burning” pain in the feet but quickly involves other systems ^[8]. Warning signs include autonomic symptoms like extreme dizziness when standing, severe diarrhea or constipation, and unexplained heart problems ^[9][10].

Why Misdiagnosis is Common

It is very common for genetic neuropathies to be mistaken for “acquired” conditions (those caused by outside factors). This happens because the clinical overlap is significant:

• CIDP and GBS: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Guillain-Barré Syndrome (GBS) are immune system attacks on the nerves ^[11]. Because they also cause weakness and slowed nerve signals, many CMT1A patients are initially misdiagnosed with CIDP ^[1]. A key difference is that CIDP usually comes on more quickly and “fluctuates,” while CMT is a slow, steady change ^[11].
• Diabetic Neuropathy: Because diabetes is so common, doctors often assume nerve pain or numbness is due to blood sugar, especially in adults. However, if symptoms are atypical for diabetes, progress unusually even with well-controlled blood sugar, or if there is a family history of foot issues, a genetic cause should be considered alongside other acquired neuropathies (like vitamin deficiencies) ^[12].

The Impact of Diagnostic Delay

The “diagnostic odyssey”—the time from the first symptom to an accurate diagnosis—often lasts over a decade for genetic neuropathy patients ^[1].

• Inappropriate Treatment: Patients misdiagnosed with CIDP may be given heavy-duty immune treatments like steroids or IVIG (Intravenous Immunoglobulin) ^[11]. These treatments do not help genetic conditions and can cause serious side effects like weight gain, high blood pressure, or bone loss ^[1].
• Missed Windows for Care: While many genetic neuropathies do not yet have a “cure,” knowing the diagnosis allows for proper physical therapy, orthopedic support, and genetic counseling for family members ^[13]. In the case of hATTR, early diagnosis is critical because new gene-silencing therapies work best when started before significant damage occurs ^[14][15].